Brogi Edi
Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Av., New York City, NY, 10065, USA.
Virchows Arch. 2022 Dec;481(6):823-837. doi: 10.1007/s00428-022-03299-3. Epub 2022 May 14.
Lobular carcinoma in situ (LCIS) is a non-invasive proliferation of atypical dyscohesive epithelial cells characterized by loss or functional alteration of E-cadherin-mediated cell adhesion. The morphologic spectrum of LCIS encompasses classic (C-LCIS), florid (F-LCIS) and pleomorphic LCIS (P-LCIS), as recently defined by the World Health Organization (WHO) Expert Consensus Group. Atypical lobular hyperplasia (ALH) is also part of this spectrum.This article highlights the morphologic and immunohistochemical features of the three forms of LCIS and summarizes their management implications and prognosis, with emphasis on F-LCIS and P-LCIS.
小叶原位癌(LCIS)是一种非侵袭性的非典型黏附性上皮细胞增殖,其特征为E-钙黏蛋白介导的细胞黏附丧失或功能改变。小叶原位癌的形态学谱包括经典型(C-LCIS)、旺炽型(F-LCIS)和多形性小叶原位癌(P-LCIS),这是世界卫生组织(WHO)专家共识小组最近定义的。非典型小叶增生(ALH)也属于这一谱。本文重点介绍了三种形式的小叶原位癌的形态学和免疫组化特征,并总结了它们的处理意义和预后,重点是旺炽型小叶原位癌和多形性小叶原位癌。